DR. MARK CHRISTOPHER GILLIS MD NPI 1992806509

NPI Details

DR. Mark Christopher Gillis, MD is a family medicine in Itasca, IL. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Mark Christopher Gillis, MD NPI is 1992806509. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1300 N ARLINGTON HEIGHTS RD STE 130
ITASCA, IL
ZIP 60143-128
Phone: (847) 871-4540
Fax: (847) 871-4597

The NPI 1992806509 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Hemoglobin a1c level (HCPCS:83036)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Vitamin d-3 level (HCPCS:82306)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Blood test, clotting time (HCPCS:85610)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) level (HCPCS:82043)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Ferritin (blood protein) level (HCPCS:82728)
• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Uric acid level, blood (HCPCS:84550)
• Folic acid level, serum (HCPCS:82746)
• Blood glucose (sugar) level (HCPCS:82947)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)

The enumeration date for this NPI number is 9/26/2006 and was last updated on 8/31/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.